Dr. Maryam Shayesteh Alam Co-Authors New Vitiligo Treatment Publication

We are proud to announce that Dr. Maryam Shayesteh Alam has co-authored a new study published in the British Journal of Dermatology, one of the most prestigious dermatology journals worldwide.

This publication examines the long-term management of vitiligo using ruxolitinib cream, comparing treatment continuation with treatment withdrawal in patients who achieved significant facial repigmentation.

The study provides important insight into treatment durability, relapse after withdrawal, and the ability to regain repigmentation after restarting active therapy.

• Continued treatment was associated with higher rates of sustained repigmentation.
• Some patients experienced relapse after treatment withdrawal.
• Repigmentation could be regained after restarting ruxolitinib cream.

At SimcoDerm Medical & Research Institute, we are committed to advancing dermatology through clinical research and contributing to innovations that improve patient care worldwide.